Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
about
MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.Non-Viral Based miR Delivery and Recent Developments.The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma
P2860
Q33863394-B443D056-55B6-4E99-91CC-58C06812013BQ45782957-9979D41D-6C38-451D-8730-25AD12308B56Q47365487-17CD4553-8747-4B35-B588-1739A98503F5Q52589516-D0028A45-6369-4168-8C19-BF981AF64D6DQ54231141-015D15E3-7122-431F-9AC2-6A0350B3C3B6Q55176168-4D4C584F-2B9A-4F6F-9963-20E9935E3D8AQ57491234-F6FAAD1F-2EAC-47FB-9A33-28958A5753D4
P2860
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
@en
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
@nl
type
label
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
@en
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
@nl
prefLabel
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
@en
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
@en
P2093
Chuan-Rui Xu
Hui-Ying Xue
Jia-Zhi Liao
Ju-Sheng Lin
Robert J Lee
Wei-Gang Yuan
Xing-Xing He
P2860
P304
86675-86686
P356
10.18632/ONCOTARGET.13431
P407
P577
2016-11-17T00:00:00Z